BioCryst Pharma (BCRX) Offers Positive Results from BCX4430 PoC Study in Ebola Virus
Go back to BioCryst Pharma (BCRX) Offers Positive Results from BCX4430 PoC Study in Ebola Virus| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 4.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.38 | 52 Week High | $10.98 | |||
| Open | $4.38 | 52 Week Low | $1.63 | |||
| Day High | $4.38 | P/E | N/A | |||
| Day Low | $4.38 | EPS | $-0.68 | |||
| Volume | 168 | |||||
